Natera Cash Conversion Cycle 2011-2026 | NTRA

Annual Cash Conversion Cycle Natera

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
81.5	58.5	61.6	72.3	86	15.5	8.89	13.7	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
86	8.89	49.8

Quarterly Cash Conversion Cycle Natera

2024-Q3	2023-Q4	2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
60.7	-	-	-	-	-	68.1	-	60.8	60.3	49.8	-	73	108	81.3	58.5	71.1	73.8	82	82.6	84.8	87.8	77.2	76	72.3	76.3	49.6	24.8	22.7	23.5	14.2	10.1	11.3	11.3	11.3	10.9	5.86	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
108	5.86	53.3

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
Agilent Technologies A	111	$ 135.53	0.11 %	$ 41.2 B	USA
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	-2.46 K	$ 8.53	-23.77 %	$ 11.3 M	USA
Castle Biosciences CSTL	31.6	$ 21.08	-4.66 %	$ 611 M	USA
Aspira Women's Health AWH	1.01 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	2.11	-	-61.36 %	$ 2.46 M	USA
Fulgent Genetics FLGT	51.8	$ 18.14	-0.55 %	$ 558 M	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Guardant Health GH	79.6	$ 129.69	-2.65 %	$ 16.3 B	USA
CareDx, Inc CDNA	51.5	$ 22.82	0.53 %	$ 1.22 B	USA
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
ICON Public Limited Company ICLR	52.5	$ 136.07	-0.53 %	$ 10.7 B	Irlanda
Interpace Biosciences IDXG	62.9	$ 1.7	-5.56 %	$ 7.52 M	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	142	$ 162.96	2.68 %	$ 25.9 B	USA
Lantheus Holdings LNTH	97.3	$ 99.3	-0.32 %	$ 6.7 B	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Mettler-Toledo International MTD	66.4	$ 1 180.58	1.47 %	$ 24.3 B	Schweiz
Charles River Laboratories International CRL	65	$ 180.71	-0.35 %	$ 8.96 B	USA
NeoGenomics NEO	82.4	$ 10.52	3.24 %	$ 1.35 B	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
National Research Corporation NRC	29.4	$ 19.53	-0.66 %	$ 437 M	USA
Medpace Holdings MEDP	50.4	$ 447.11	-0.23 %	$ 12.9 B	USA
Exact Sciences Corporation EXAS	42.5	-	-	$ 19.8 B	USA
Myriad Genetics MYGN	49.3	$ 3.97	-5.92 %	$ 368 M	USA
Personalis PSNL	-1.89	$ 11.4	3.83 %	$ 1.02 B	USA
Koninklijke Philips N.V. PHG	89	$ 26.39	-0.23 %	$ 25 B	Niderland
Senseonics Holdings SENS	36.1	$ 6.79	1.04 %	$ 283 M	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	-398	-	-	$ 2.69 B	USA
Twist Bioscience Corporation TWST	83.6	$ 66.87	-3.13 %	$ 4 B	USA
Biomerica BMRA	172	$ 2.39	-1.74 %	$ 5.49 M	USA
Laboratory Corporation of America Holdings LH	40.3	$ 260.06	-0.75 %	$ 21.6 B	USA
Thermo Fisher Scientific TMO	70	$ 492.51	1.09 %	$ 186 B	USA
Trinity Biotech plc TRIB	136	$ 0.7	-0.16 %	$ 251 M	Irlanda
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	150	$ 8.97	-3.55 %	$ 1.95 B	USA
Quest Diagnostics Incorporated DGX	39.5	$ 194.9	-0.72 %	$ 21.6 B	USA
Invitae Corporation NVTA	299	-	-	$ 21.2 M	USA